MENU
Advertisement
With commentary from Michael P. Thompson, PhD
Reprints
View Supplement
COAPT 5-Year Data Demonstrate Benefits of Mitral TEER, Reveal Need to Address Underlying LV Dysfunction
With commentary from Gregg Stone, MD
left-arrow Created with Sketch. Previous Article
Renal Denervation: Where We Stand After the FDA Panels
With Ajay J. Kirtane, MD, SM; Eric A. Secemsky, MD, MSc, RPVI, FACC, FSCAI, FSVM; and Taisei Kobayashi, MD
Next Article right-arrow Created with Sketch.
Modern Clinical Trials Spotlight
Insights on current trial designs, inclusivity, and next steps.
View Issue
The Cath Lab Cliff: A Warning Sign of a System in Fracture
By Joel Sauer, MBA, and Ana A. Mercurio-Pinto, MHM
CT-Guided PCI: Toward Precision in Case Triage and Procedural Planning
By Yader Sandoval, MD, and Emmanouil S. Brilakis, MD, PhD
An Interview With Nidhi Madan, MD, MPH
Advancing Structural Heart Care With Automation and AI
With Haytham Allaham, MD; Megan Coylewright, MD, MPH, FACC, FSCAI; and Mukta Srivastava, MD
The Role of Cardiac CT for Successful TAVR Planning
By Harika Sai Dabbara, MD, and Lauren Sharan Ranard, MD, MS
